MS News & Perspectives

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article on how oral fesoterodine fumarate tablets can reduce urinary disorders and improve quality of life for people with bladder impairment due to MS. Price also reads “Can Focusing on the Epstein-Barr Virus Help Researchers Fight MS?”, a column by Ed Tobias.=================================== Are you interested in learning more about multiple sclerosis? If so, please visit:https://multiplesclerosisnewstoday.com/=====================================To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses a news article about how European Medicines Agency committee is recommending that Vumerity be approved for adults with relapsing-remitting multiple sclerosis in the EU; plus, Price reads the column by Jennifer Powell, Silver Linings, “When Loss Is Expected, How Do We Cope?”.===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/

=====================================To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how rim lesions, thought to indicate chronic brain inflammation, were found in about 4 of every 10 patients; declined with age, disease duration; and reads “Despite the Nerves, I Attended My First Family Gathering in 2 Years”, a column by John Connor.===================================Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.

https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud ===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:https://multiplesclerosisnewstoday.com/=====================================To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses an article about a class of molecules called positive allosteric modulators (PAMS) may be used to treat pain caused by nerve damage, a common symptom of MS.Price also reads a column by Ed Tobias, MS Wire, “I’m Sleeping Better These Days, but Why?”.===================================Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.

https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud ===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/

=====================================To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses an article on how bladder and bowel problems should be monitored regularly in MS patients to better adapt treatment plans and improve quality of life; plus, reads “Overcoming My Fear of Concerts With a Little Help From the Rolling Stones”, a column by Jennifer Powell.===================================Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.

https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud ===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/

=====================================To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about how chronic Inflammation in MS can be linked to specific brain cells, a recent study showed; and also reads “All Change Please, the Medical Equipment You’re Using Ends Here”, a column by John Connor.===================================Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.

https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud ===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/

=====================================To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses a news article about how a study found MS and depression doubled patients' vascular disease risk over 10 years, and relative to controls greatly raised risk of death.Also, Price Wooldridge, reads “I’m Grateful for My COVID-19 Booster Shot”, a column by Ed Tobias.===================================Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.

https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud ===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:https://multiplesclerosisnewstoday.com/=====================================To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge discusses an article about on how a study of immigrants with MS to Ontario, relative to residents with MS, found mood disorders and other comorbidities prevalent.Also, Price reads “Emotional and Physical Pain Are My Unwanted Sidekicks”, a column by Jennifer Powell.===================================Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.

https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud ===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:https://multiplesclerosisnewstoday.com/=====================================To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about how pro-inflammatory T helper 17 (Th17) immune cells directly interact with myelin-producing cells, promoting their damage and death.Price also reads “The Painful Tooth: My Weekend of Agony”, a column by John Connor.===================================Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.

https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud ===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article on how people who had been infected with the T. gondii parasite were 32% less likely to develop multiple sclerosis than those who had not.Price also reads the column by Ed Tobias, MS Wire, “Researchers Lower the Temperature to Try to Reduce MS Inflammation”.===================================Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.

https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud ===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/

=====================================To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/